Medication info
Glupen Tablet 2mg (Glymepiride)

Glupen Tablet 2mg (Glymepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Farmgen Science Co., Ltd.
Appearance
Green, rectangular tablet
Packaging
30 tablets, 100 tablets/bottle
Approval status
Active

MFDS item code 200402485 · Notified 2004.07.15 · Insurance code 670100020

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This drug is administered orally once daily. This drug should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit with doses above 4 mg, but some patients showed better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider use in combination with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's requirement for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no exact dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is advisable to follow the method described under Initial dose. That is, start treatment with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered drug should be taken into consideration. 4) Dose adjustment While taking this drug, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly corrected by immediate intake of sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this drug with insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. This drug is administered at a dose of 8 mg once daily with the first meal, while insulin is started at a low dose and increased at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Clinical data have been published on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this drug and metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Farmgen Science Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

  • Abnormal blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used as an adjunct to dietary and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can be administered alone and, if adequate blood sugar control is not achieved with oral hypoglycemic agents, can be combined with insulin. Furthermore, when glycemic control is difficult with sulfonylureas or metformin monotherapy, it can be used in combination with metformin to enhance blood sugar control. This medication effectively improves blood sugar levels in patients with type 2 diabetes by complementing various treatment modalities.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This drug is administered orally once daily. This drug should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit with doses above 4 mg, but some patients showed better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider use in combination with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's requirement for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no exact dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is advisable to follow the method described under Initial dose. That is, start treatment with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered drug should be taken into consideration. 4) Dose adjustment While taking this drug, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly corrected by immediate intake of sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this drug with insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. This drug is administered at a dose of 8 mg once daily with the first meal, while insulin is started at a low dose and increased at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Clinical data have been published on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this drug and metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes or in those with diabetic ketoacidosis or diabetic coma. It is also contraindicated in patients allergic to this medication or sulfonylurea drugs, as well as in those with severe liver or kidney dysfunction. Women who are pregnant or may become pregnant, and those who are breastfeeding, should also refrain from using this medication. Insulin therapy is recommended for patients with severe infections or those undergoing surgery or with serious trauma, thus this medication should be avoided. Patients with gastrointestinal disorders that impair food absorption should be cautious due to the risk of hypoglycemia. Patients with genetic lactose intolerance or specific enzyme deficiencies should not take this medication. During the first week of taking this medication, the risk of hypoglycemia is heightened, so blood sugar levels should be closely monitored. Elderly patients, those with poor nutritional status or irregular eating patterns, frequent alcohol consumers, and patients with weakened kidney or liver function should be attentive. Additionally, those with thyroid disorders or other endocrine issues may also have an increased risk of hypoglycemia. When taking other medications, blood sugar changes may occur due to interactions, so consultation with a physician is necessary. This medication can induce hypoglycemia, with symptoms including headache, severe hunger, nausea, fatigue, confusion, drowsiness, and loss of consciousness. Severe hypoglycemia may present with symptoms similar to a stroke, so immediate ingestion of sugar or assistance from medical personnel is required. Also, in the initial period of taking this medication, blurred vision, gastrointestinal symptoms, liver function abnormalities, blood anomalies, and allergic reactions may rarely occur. To maintain blood sugar control, medication use must be combined with dietary management, exercise therapy, and weight control. Patients and their families should be sufficiently educated about hypoglycemia symptoms and risks, and be prepared to consume sugar immediately if hypoglycemia occurs. In situations of high stress, surgery, or infection where blood sugar control becomes difficult, transitioning to insulin therapy is advisable. This medication is excreted via the liver and kidneys; therefore, elderly patients or those with impaired kidney function should adjust the dosage, and in cases of overdose, serious hypoglycemia may occur, necessitating immediate medical attention. To store this medication safely, keep it out of reach of children and store it sealed in its original container. Lastly, women who are pregnant or breastfeeding should not take this medication without consulting a physician.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorder, anxiety, aggression, decreased concentration, decreased agility or energy, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, arrhythmia, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, difficulty breathing, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbance, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from exposure to air and moisture, and it is important to maintain storage temperatures between 1 degree and 30 degrees Celsius room temperature. This will safely maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Green, rectangular tablet

Package unit

30 tablets, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.